DIZE (Dexamethasone, Idarubicin, and Continuous Infusion of Ifosfamide and Etoposide): an Effective and Well-Tolerated New Regimen for Patients with Relapsed Lymphoma-Reference-Cited by-同舟云学术

DIZE (Dexamethasone, Idarubicin, and Continuous Infusion of Ifosfamide and Etoposide): an Effective and Well-Tolerated New Regimen for Patients with Relapsed Lymphoma

Published:1998-01 Issue:3-4 Volume:31 Page:359-366
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Reiser M.,Schnell R.,Straub G.,Borchmann P.,Wilhelm M.,Übelacker R.,Wörmann B.,Münch R.,Diehl V.,Engert A.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199809059229

Reference25 articles.

1. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy

2. Results of MIME salvage regimen for recurrent or refractory lymphoma.

3. Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma

4. Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, In Vitro Anticancer, Anti-Inflammatory and DNA Binding Activity of Thiazolidinedione Derivatives;Anti-Cancer Agents in Medicinal Chemistry;2020-10-14

2. Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma;Expert Opinion on Drug Metabolism & Toxicology;2011-09-12

3. Pixantrone for the treatment of aggressive non-Hodgkin lymphoma;Expert Opinion on Pharmacotherapy;2010-06-23

4. Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas;Future Oncology;2009-05

5. Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas;Expert Opinion on Investigational Drugs;2007-10